Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze

Pharmacology Biochemistry and Behavior

Volumn 90, Issue 4, 2008, Pages 545-550

  Stern, C A J ^a   Carobrez, A P ^a   Bertoglio, L J ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Aversive learning; Emotional memory; Midazolam; One trial tolerance; Propranolol

Indexed keywords

MIDAZOLAM; PROPRANOLOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; KNOWLEDGE; LEARNING; MALE; MAZE TEST; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DOSE-RESPONSE RELATIONSHIP, DRUG; LEARNING; MALE; MIDAZOLAM; PROPRANOLOL; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS; RODENTIA;

EID: 48749120077     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.04.013     Document Type: Article

References (27)

1. Audi E.A., de-Oliveira C.E., and Graeff F.G. Serotonergic mediation of the anxiolytic effect of intracerebrally injected propranolol measured in the elevated plus-maze. Braz J Med Biol Res 22 (1989) 699-701
2. Bertoglio L.J., and Carobrez A.P. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav Brain Res 108 (2000) 197-203
3. Bertoglio L.J., and Carobrez A.P. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacol Biochem Behav 72 (2002) 449-455
4. Bertoglio L.J., and Carobrez A.P. Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behav Pharmacol 15 (2004) 45-54
5. Bertoglio L.J., Anzini C., Lino-de-Oliveira C., and Carobrez A.P. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats. Behav Brain Res 162 (2005) 99-107
6. Bertoglio L.J., Joca S.R., and Guimarães F.S. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav Brain Res 175 (2006) 183-188
7. Cahill L., Prins B., Weber M., and McGaugh J.L. Beta-adrenergic activation and memory for emotional events. Nature 371 (1994) 702-704
8. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29 (2005) 1193-1205
9. Chamberlain S.R., Müller U., Blackwell A.D., Robbins T.W., and Sahakian B.J. Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology (Berl) 188 (2006) 397-407
10. Cruz A.P., Frei F., and Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49 (1994) 171-176
11. Dal-Cól M.L.C., Orlandi-Pereira L., Rosa V.P., Calixto A.V., Carobrez A.P., and Faria M.S. Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1. Pharmacol Biochem Behav 74 (2003) 395-400
12. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res 58 (1993) 199-202
13. File S.E., Mabbutt P.S., and Hitchcott P.K. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology (Berl) 102 (1990) 98-101
14. File S.E., Gonzalez L.E., and Gallant R. Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology 19 (1998) 397-405
15. File S.E., Gonzalez L.E., and Gallant R. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology 21 (1999) 312-320
16. Gold P.E., Vogt J., and Hall J.L. Glucose effects on memory: behavioral and pharmacological characteristics. Behav Neural Biol 46 (1986) 145-155
17. Gorman A.L., and Dunn A.J. Beta-adrenergic receptors are involved in stress-related behavioral changes. Pharmacol Biochem Behav 45 (1993) 1-7
18. Griebel G., Rodgers R.J., Perrault G., and Sanger D.J. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety. Neuropharmacology 39 (2000) 1848-1857
19. Kalueff A.V., and Murphy D.L. The importance of cognitive phenotypes in experimental modeling of animal anxiety and depression. Neural Plast 2007 (2007) 52087
20. Lamprea M.R., Cardenas F.P., Silveira R., Morato S., and Walsh T.J. Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: forebrain cholinergic mechanisms. Behav Brain Res 117 (2000) 97-105
21. Lennartz R.C., Hellems K.L., Mook E.R., and Gold P.E. Inhibitory avoidance impairments induced by intra-amygdala propranolol are reversed by glutamate but not glucose. Behav Neurosci 110 (1996) 1033-1039
22. Middlemiss D.N. Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol. Eur J Pharmacol 101 (1984) 289-293
23. Pessoa L. On the relationship between emotion and cognition. Nat Rev Neurosci 9 (2008) 148-158
24. Rodgers R.J., Johnson N.J., Cole J.C., Dewar C.V., Kidd G.R., and Kimpson P.H. Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade. Pharmacol Biochem Behav 54 (1996) 41-50
25. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44 (1993) 463-469
26. van Stegeren A.H., Everaerd W., Cahill L., McGaugh J.L., and Gooren L.J. Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents. Psychopharmacology (Berl) 138 (1998) 305-310
27. Vargas K.M., Da Cunha C., and Andreatini R. Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 30 (2006) 1394-1402